Cited by 414Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration MechanismsPsoriasis: Treatment and Pathogenesis

Exploring the origins of grey matter damage in multiple sclerosis

Open access
Calabrese, Massimiliano, Magliozzi, Roberta, Ciccarelli, Olga, Geurts, Jeroen J. G., Reynolds, Richard, Martin, Roland·2015·Nature Reviews Neuroscience

Abstract

Multiple sclerosis is characterized at the gross pathological level by the presence of widespread focal demyelinating lesions of the myelin-rich white matter. However, it is becoming clear that grey matter is not spared, even during the earliest phases of the disease. Furthermore, grey matter damage may have an important role both in physical and cognitive disability. Grey matter pathology involves both inflammatory and neurodegenerative mechanisms, but the relationship between the two is unclear. Histological, immunological and neuroimaging studies have provided new insight in this rapidly expanding field, and form the basis of the most recent hypotheses on the pathogenesis of grey matter damage.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrn3900

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Spinal cord pathology is an important determinant of permanent neurological disability in multiple sclerosis, with cardinal characteristics being inflammatory demyelination, synaptic, neuronal and axonal loss.

    “Spinal cord pathology is an important determinant of permanent neurological disability with cardinal characteristics being inflammatory demyelination, synaptic, neuronal and axonal loss.6, 7, 8, 9, 10, 11”

    From Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology? (2017) · cites this paper as [7]

    The introduction (p. 2) describes multiple sclerosis pathology as involving inflammation, demyelination, and axonal and neuronal damage. The discussion of spinal-cord cases (p. 8) links inflammation with diffuse axonal loss. But the paper does not establish spinal-cord pathology as an important determinant of permanent disability or identify synaptic loss as a cardinal feature of spinal-cord pathology. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Most EAE models do not recapitulate the extensive grey matter pathology observed in patients, which show a demyelination pattern often characterized by chronic microglia activation, absence of leukocyte infiltration and pronounced meningeal inflammation.

    “Furthermore, most EAE models do not recapitulate the extensive grey matter pathology observed in patients, which show a demyelination pattern often characterized by chronic microglia activation, absence of leukocyte infiltration [46] and pronounced meningeal inflammation [156].”

    From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [46]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

1 of the 131 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Calabrese, M., Magliozzi, R., Ciccarelli, O., Geurts, J. J. G., Reynolds, R., & Martin, R.
Affiliations
  • University of Verona (IT)
  • Istituto Superiore di Sanità (IT)
  • University College London Hospitals NHS Foundation Trust (GB)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
  • Hammersmith Hospital (GB)
Corresponding author
Calabrese, Massimiliano
Venue
Nature Reviews Neuroscience
Published
2015-02-20
Volume
16
Issue
3
Pages
147-158
ISSN
  • 1471-003X (ISSN-L)
  • 1471-0048
OpenAlex
W1972438508
Cited by
414
References
131
Citations by year
2026: 24 · 2025: 30 · 2024: 33 · 2023: 22 · 2022: 31 · 2021: 58 · 2020: 45 · 2019: 47 · 2018: 40 · 2017: 39 · 2016: 29 · 2015: 16
FWCI
6.06
Type
journal article
Language
en
Open access
Locations
  • Nature reviews. Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • UCL Discovery (University College London) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • National Science Foundation (2313255)
  • Fondazione Italiana Sclerosi Multipla
  • International Progressive MS Alliance
  • Multiple Sclerosis Society
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Ministero della Salute (GR-2010-2313255, GR-2010)
  • Universität Zürich
  • Schweizerische Multiple Sklerose Gesellschaft
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
multiple sclerosis, demyelination, neurodegeneration, neuroinflammation, white matter injury, cognitive disability, pathogenesis
MeSH terms
Animals, Cerebral Cortex, Humans, Inflammation, Multiple Sclerosis, White Matter, Gray Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review